MedPath

Treatment of Excessive abnormalwhite vaginal Discharge with Unani medicine Majoon Sohag Sonth

Phase 3
Not yet recruiting
Conditions
Other noninflammatory disorders ofvagina,
Registration Number
CTRI/2019/03/017950
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM
Brief Summary

This study is designed as a multicentric open trial in patients with **SayalÄn al-Rahim (Excessive Abnormal Vaginal Discharge)** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically on Baseline and of treatment.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be four weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

**Composition of*****Sharbat Sadar***

| | | | |

| --- | --- | --- | --- |

|**S.No.**

**Ingredients**

**Scientific Name**

**Quantity**

|

Zanjabeel

*Zingiber Officinalis*

200 gm

|

Rougan Zard

*Ghee*

200 gm

|

Sheer e Gao

*Cow’s Milk*

1.2 litre

|

Qand Safaid

*Sugar*

1 kg

|

Maghz-e-Tukhm-e-Kharbuza

*Cucumis melo Linn*.

50 gm

|

Maghz-e-Habb-us-samena

*Buchanauia angustifolia Roxb*.

40 gm

|

Nishasta Gandum

*Triticum aestivum Linn*.

40 gm

|

Asgand

*Withania Somnifera Dunal*.

20 gm

|

Musli Safaid

*Chlorphytum arundinaceum baker*.

20 gm

|

Mocharas

*Salmalia malabarica*

20 gm

|

Samagh e Arabi

*Acacia arabica*

20 gm

|

Satawar

*Asparagus racemosus Willd**.*

20 gm

|

Sazaj Hindi

*Cinnamomum tamala*

15 gm

|

Sandal Safaid

*Santalum album Linn*.

15 gm

|

Saleekha

*Cinnamomum cassia Blume*.

15 gm

|

Gul-e-Dhawa

*Anogeissus Latifolia*

15 gm

|

Khar-e-Khasak

*Tribulus terrestris Linn*.

10 gm

|

Filfil Daraz

*Piper longum Linn*.

10 gm

|

Filfil Siyah

*Piper nigrum Linn*.

10 gm

|

Sunbul-ut-Teeb

*Nardostachys jatamansi Dc*.

10 gm

|

Saad Kufi

*Cyperus rotundus Linn*.

10 gm

|

Maghz-e-Tukhm-e-Konch

*Mucuna Prurita Hook*

10 gm

|23.

Samagh-e-Dhak

*Butea monosperma*

10 gm

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
240
Inclusion Criteria
  • Sexually active women of age group 18 – 45 years.
  • All women complaining of vaginal discharge.
  • Associated symptoms: a.
  • Vulval Itching b.
  • Low Backache c.
  • Generalised weakness d.
  • Burning Micturition e.
  • Abnormal Vaginal Odour.
Exclusion Criteria
  • Menopausal, Pregnant and Lactating women.
  • Patient having any systemic illness like hypertension, diabetes mellitus.
  • Patients with fibroid, polyp, ovarian tumour or cyst, prolapse and malignancy.
  • Patients using OCPs or intrauterine devices.
  • Patients on long-term medications.
  • Abnormal findings on pelvic sonography.
  • Patients having acute / acute on chronic/ Chronic PID as per CDC Criteria (Annexure-V).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in signs and symptoms of SayalÄn al-Rahim (Excessive Abnormal Vaginal Discharge)4 weeks
Secondary Outcome Measures
NameTimeMethod
Haematological and biochemical assessment for safety assessmentInvestigations will be done at baseline and end of treatment

Trial Locations

Locations (3)

Central Research Institute of Unani Medicine (CRIUM)

🇮🇳

Lucknow, UTTAR PRADESH, India

Clinical Research Unit (CRU)

🇮🇳

Meerut, UTTAR PRADESH, India

Regional Research Institute of Unani Medicine (RRIUM)

🇮🇳

JAMMU, & KASHMIR, India

Central Research Institute of Unani Medicine (CRIUM)
🇮🇳Lucknow, UTTAR PRADESH, India
Dr Najmus Sehar
Principal investigator
7903422298
nsehar.ccrum@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.